These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23483759)

  • 1. Presence of differentiating neuroblasts in bone marrow is a favorable prognostic factor for bone marrow metastatic neuroblastoma at diagnosis.
    Park SH; Kim S; Park CJ; Jang S; Chi HS; Koh KN; Im HJ; Seo JJ
    Ann Lab Med; 2013 Mar; 33(2):89-96. PubMed ID: 23483759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ppGalNAc-T13: a new molecular marker of bone marrow involvement in neuroblastoma.
    Berois N; Blanc E; Ripoche H; Mergui X; Trajtenberg F; Cantais S; Barrois M; Dessen P; Kågedal B; Bénard J; Osinaga E; Raguénez G
    Clin Chem; 2006 Sep; 52(9):1701-12. PubMed ID: 16873292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow of neuroblastoma patients shows downregulation of CXCL12 expression and presence of IFN signature.
    Scaruffi P; Morandi F; Gallo F; Stigliani S; Parodi S; Moretti S; Bonassi S; Fardin P; Garaventa A; Zanazzo G; Pistoia V; Tonini GP; Corrias MV
    Pediatr Blood Cancer; 2012 Jul; 59(1):44-51. PubMed ID: 21994039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical characteristics and prognosis of high-risk neuroblastoma with bone marrow metastasis in children].
    Fan HJ; Huang C; Su Y; Wang XD; Zhou YC; Duan C; Zhao W; Zhao Q; Jin M; Ma XL
    Zhonghua Er Ke Za Zhi; 2019 Nov; 57(11):863-869. PubMed ID: 31665841
    [No Abstract]   [Full Text] [Related]  

  • 5. Minimal residual disease is a prognostic marker for neuroblastoma with bone marrow infiltration.
    Cai JY; Pan C; Tang YJ; Chen J; Ye QD; Zhou M; Xue H; Tang JY
    Am J Clin Oncol; 2012 Jun; 35(3):275-8. PubMed ID: 21537148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined use of multiparametric flow cytometry and cytomorphology to enhance detection of neuroblastoma metastatic cells in bone marrow.
    Manenq C; Lesesve JF; Dreumont N; Massin F; Salignac S; Mansuy L; Chastagner P; Latger-Cannard V; Broséus J
    Int J Lab Hematol; 2020 Feb; 42(1):52-60. PubMed ID: 31821742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic value of the determination of bone marrow lesion in patients with neuroblastoma based on the gene PHOX2B and TH expression].
    Druĭ AE; Shorikov EV; Tsaur GA; Popov AM; Tuponogov SN; Savel'ëv LI; Tsvirenko SV; Fechina LG
    Vopr Onkol; 2014; 60(2):57-62. PubMed ID: 24919263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the MDR1 gene product P-glycoprotein in childhood neuroblastoma.
    Dhooge CR; De Moerloose BM; Benoit YC; Van Roy N; Philippé ; Laureys GG
    Cancer; 1997 Oct; 80(7):1250-7. PubMed ID: 9317175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TH and DCX mRNAs in peripheral blood and bone marrow predict outcome in metastatic neuroblastoma patients.
    Yáñez Y; Hervás D; Grau E; Oltra S; Pérez G; Palanca S; Bermúdez M; Márquez C; Cañete A; Castel V
    J Cancer Res Clin Oncol; 2016 Mar; 142(3):573-80. PubMed ID: 26498952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of initial bone marrow disease detection by multiparameter flow cytometry in children with neuroblastoma.
    Popov A; Druy A; Shorikov E; Verzhbitskaya T; Solodovnikov A; Saveliev L; Tytgat GAM; Tsaur G; Fechina L
    J Cancer Res Clin Oncol; 2019 Feb; 145(2):535-542. PubMed ID: 30603901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of fast molecular response of marrow disease in patients aged over 1 year with stage 4 neuroblastoma.
    Stutterheim J; Zappeij-Kannegieter L; Versteeg R; Caron HN; van der Schoot CE; Tytgat GA
    Eur J Cancer; 2011 May; 47(8):1193-202. PubMed ID: 21429738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of morphological/immunohistochemical versus nuclear medicine imaging modalities in detecting metastatic bone and/or marrow deposits in neuroblastoma patients.
    Zaher Ael-S; Zaher AM; Moneer MM; El Gamal BM
    J Egypt Natl Canc Inst; 2011 Jun; 23(2):79-88. PubMed ID: 22099965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Analysis of Flow Cytometry and Cytomorphology for Neuroblastoma Cell Detection in Effusion and Bone Marrow Specimens.
    Ye W; Wang J; Li W; Shen H
    Fetal Pediatr Pathol; 2019 Feb; 38(1):1-7. PubMed ID: 30667298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
    Horibe K; Fukuda M; Miyajima Y; Matsumoto K; Kondo M; Inaba J; Miyashita Y
    Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Significance of Persistent Tumor in Bone Marrow during Treatment of High-risk Neuroblastoma.
    Choi YB; Bae GE; Lee NH; Kim JS; Lee SH; Yoo KH; Sung KW; Koo HH
    J Korean Med Sci; 2015 Aug; 30(8):1062-7. PubMed ID: 26240483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological detection and definition of minimal residual neuroblastoma disease in bone marrow samples obtained during or after therapy.
    Gussetis ES; Ebener U; Wehner S; Kornhuber B
    Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1745-53. PubMed ID: 2698803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic influence of minimal residual disease detected by flow cytometry and peripheral blood stem cell transplantation by CD34+ selection in childhood advanced neuroblastoma.
    Cai JY; Tang YJ; Jiang LM; Pan C; Chen J; Tang JY
    Pediatr Blood Cancer; 2007 Dec; 49(7):952-7. PubMed ID: 17514736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphologic alteration of metastatic neuroblastic tumor in bone marrow after chemotherapy.
    Bae GE; Suh YL; Sung KW; Kim JS
    Korean J Pathol; 2013 Oct; 47(5):433-42. PubMed ID: 24255631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic value of bone marrow lesions in children with neuroblastoma detected by flow cytometry].
    Popov AM; Shorikov EV; Verzhditskaia TIu; Tsaur GA; Druĭ AE; Solodovnikov AG; Savel'ev LI; Fechina LG
    Vopr Onkol; 2014; 60(4):469-75. PubMed ID: 25552066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two methods for evaluating bone marrow metastasis of neuroblastoma: Reverse transcription-polymerase chain reaction for tyrosine hydroxylase and magnetic resonance imaging.
    Takemoto C; Nishiuchi R; Endo C; Oda M; Seino Y
    Pediatr Int; 2004 Aug; 46(4):387-93. PubMed ID: 15310300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.